Q301--Kidney Disease Genetic Panel

The Department of Veterans Affairs, Veterans Integrated Service Network 10 Contracting Office has published a Special Notice announcing its intention to award a single-source contract to Natera, Inc. for chronic kidney disease (CKD) gene panel testing services. The contract will support the Pathology and Laboratory Service at the Richard L. Roudebush VA Medical Center in Indianapolis, Indiana, under FAR 13.106(b)(2) authority. This procurement is classified under NAICS code 621511 (Medical Laboratories) and PSC Q301 (Reference Laboratory Testing), with a size standard of $41.5 million. The notice was posted on March 25, 2026, and a prior sources sought notice was completed on March 13, 2026. This is not a competitive solicitation, and no formal solicitation package will be made available to interested parties.

The objective of this Special Notice is to provide interested contractors the opportunity to demonstrate that competition would be advantageous to the Government before the VA proceeds with the single-source award to Natera, Inc. Interested parties must submit written responses providing clear and convincing evidence supporting competition by the deadline of March 27, 2026, at 1:00 PM Eastern Time, sent via email to Jessica.Bryant5@va.gov. No telephone inquiries will be accepted. While this is a single-source procurement announcement rather than a traditional competitive opportunity, any contractor may respond if they can substantiate competitive advantages to the Government. The one-year contract will provide specialized laboratory testing services for chronic kidney disease genetic panel analysis to support clinical operations at the Richard L. Roudebush VA Medical Center.